Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what he has made of the potential merits of using pancreatic enzyme replacement therapy for people with cystic fibrosis.

The National Institute for Health and Care Excellence (NICE) develops authoritative, evidence-based guidance for the National Health Service on best practice, based on an assessment of clinical and cost effectiveness. The NICE’s guideline on the diagnosis and management of cystic fibrosis recommends pancreatic enzyme replacement therapy as a treatment option for exocrine pancreatic insufficiency in patients with cystic fibrosis. The guideline is available at the following link:

https://www.nice.org.uk/guidance/ng78